
Last update at
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Income before tax | 26728.10M | 23521.10M | 18470.00M | 12259.10M | 15262.60M |
| Net income | 19110.00M | 16563.80M | 12450.00M | 7771.80M | 12518.80M |
| Total Revenue | 115160.90M | 107278.40M | 94640.00M | 84188.00M | 78862.30M |
| Gross Profit | 87401.90M | 80416.30M | 67290.00M | 58813.30M | 56509.30M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 149900.00M | 150605.80M | 150120.00M | 130998.40M | 140746.50M |
| Intangible assets | 42630.00M | 45828.20M | 50890.00M | 35460.60M | 39840.30M |
| Other current assets | 5240.00M | 4841.10M | 3030.00M | 3120.00M | 4510.00M |
| Deferred long term liab | - | - | - | - | - |
| Non current assets other | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Change in Cash | -2621.40M | 3266.10M | 1100.00M | -1741.60M | -892.60M |
| Operating Cash | 25850.00M | 32660.80M | 23680.00M | 18029.90M | 20106.90M |
| Free Cash Flow | 19740.00M | 28333.00M | 17940.00M | 16004.20M | 16755.40M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
| Company | Change | Price | Market Cap (M) | P/E Ratio |
|---|---|---|---|---|
| TORNTPHARM Torrent Pharmaceuticals Limited |
39.90 1.00% | 4027.10 | 1362716.66 | 63.48 |
| SUNPHARMA Sun Pharmaceutical Industries Limited |
75.40 4.63% | 1703.30 | 4224508.76 | 40.32 |
| DIVISLAB Divi's Laboratories Limited |
336.50 5.65% | 6289.00 | 1752225.28 | 70.47 |
| CIPLA Cipla Limited |
16.40 1.25% | 1328.00 | 1183505.97 | 21.74 |
| DRREDDY Dr. Reddy's Laboratories Limited |
53.70 4.54% | 1236.20 | 1004813.29 | 17.16 |
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.
Torrent House, Ahmedabad, India, 380009
| Name | Title | Year Born |
|---|---|---|
| Mr. Samir Uttamlal Mehta | Exec. Chairman & MD | 1964 |
| Mr. Jinesh Shah B.Sc., MBA | Exec. Director of Operations & Whole Time Director | 1977 |
| Mr. Sudhir Menon CA, CWA | Exec. Director of Fin. & CFO | 1972 |
| Mr. Chintan Trivedi | Company Sec. & Compliance Officer | NA |
| Mr. Abdullah Salam Said Al Abri | Chief Customer Service Officer | NA |
| Mr. R. Chandrashekhar Inter CA | VP of Procurement | 1969 |
| Jaydip Bhatt | VP of Human Resource | 1953 |
| H. L. Guttikar B.E., MMS | VP of Projects | 1963 |
| Ashish Hajarnish M.Pharm | VP of Works | 1968 |
| Hasmukh Patel B.Pharm, M.Pharm. | VP of Works | 1968 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.